AstraZeneca/Oxford vaccine doses from 4 weeks to 8-12 weeks in Indian context, the central government has said.The vaccine also available in India, manufactured by the Serum Institute of India (SII) under the name covishield is being administered at an interval of 4 weeks.
The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has been reviewing the evidence on the vaccine’s effectiveness on new virus SARS CoV-2 variants and made significant recommendations in the backdrop of the decision of South Africa to halt the rollout of the Oxford-AstraZeneca vaccine after preliminary clinical trial findings of a study published by the Wits Vaccines and Infectious Diseases Analytics Research Unit indicated the vaccine offered minimal.